SCHEMBL14847747

SCHEMBL14847747

CC1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.68
SLC6A4 P31645 7/20 0.68
SLC6A3 Q01959 7/20 0.68
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
CYP3A4 P08684 5/20 0.67
CYP1A2 P05177 3/20 0.67
CYP2C19 P33261 3/20 0.67
NPC1 O15118 2/20 0.67
CYP2D6 P10635 2/20 0.67
MTOR P42345 2/20 0.67
RAB9A P51151 2/20 0.67
MLNR O43193 1/20 0.67
NR1I2 O75469 1/20 0.67
ABCB11 O95342 1/20 0.67
ESR1 P03372 1/20 0.67
CHRM2 P08172 1/20 0.67
CHRM4 P08173 1/20 0.67
ABCB1 P08183 1/20 0.67
ADRB1 P08588 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20340495 1.00 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL17449193 1.00 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL10041959 1.00 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL10041958 1.00 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL14094856 1.00 SLC6A2 (0.68) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL18888709 0.88 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL10050929 0.88 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL26822591 0.85 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL15249579 0.81 SLC6A2 (0.64) SLC6A2SLC6A4SLC6A3MEN1KMT2A
Desmethylsertraline SCHEMBL4570539 0.81 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3570814-B1 MOLECULAR ADJUVANTS FOR ENHANCED CYTOSOLIC DELIVERY OF ACTIVE AGENTS UNIV GENT (BE) 2023-11-29 EP disclosed
WO-2018144385-A1 ENAMIDE PROCESS SUNOVION PHARMACEUTICALS INC. (US) 2018-08-09 WO disclosed
EP-2760839-B1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2015-11-25 EP disclosed
WO-2013049104-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-04 WO disclosed